CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection
暂无分享,去创建一个
[1] J. A. Hobbs,et al. Selective Loss of Natural Killer T Cells by Apoptosis following Infection with Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.
[2] M. Kronenberg,et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.
[3] M. Brenner,et al. CD1-specific T cells in microbial immunity. , 2001, Current opinion in immunology.
[4] F. Graziano,et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. , 2001, Journal of immunological methods.
[5] C. Biron,et al. NK cells and NKT cells in innate defense against viral infections. , 2001, Current opinion in immunology.
[6] G. Giaccone,et al. Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage , 2001 .
[7] C. Aiken,et al. Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope , 2001, Journal of Virology.
[8] James J. Campbell,et al. Unique Subpopulations of CD56+ NK and NK-T Peripheral Blood Lymphocytes Identified by Chemokine Receptor Expression Repertoire1 , 2001, The Journal of Immunology.
[9] T. Sumida,et al. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. , 2001, Arthritis and rheumatism.
[10] S. Tahir,et al. CD1d‐reactive T‐cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus , 2001, Journal of leukocyte biology.
[11] S. Joyce,et al. CD1d and natural T cells: how their properties jump-start the immune system , 2001, Cellular and Molecular Life Sciences CMLS.
[12] E. Kunkel,et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.
[13] Eric J. Kunkel,et al. CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.
[14] M. Taniguchi,et al. Recognition and function of Vα14 NKT cells , 2000 .
[15] L. Bockenstedt,et al. Cutting Edge: CD1d Deficiency Impairs Murine Host Defense Against the Spirochete, Borrelia burgdorferi1 , 2000, The Journal of Immunology.
[16] M. Smyth,et al. NKT cells: facts, functions and fallacies. , 2000, Immunology today.
[17] H. Macdonald,et al. Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.
[18] F. Sallusto,et al. Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression , 2000, Immunological reviews.
[19] A. Fauci,et al. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis , 2000, Immunological reviews.
[20] E. Butcher,et al. The Primate Lentiviral Receptor Bonzo/STRL33 Is Coordinately Regulated with CCR5 and Its Expression Pattern Is Conserved Between Human and Mouse1 , 2000, The Journal of Immunology.
[21] M. Taniguchi,et al. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. , 2000, International immunology.
[22] Robert F. Siliciano,et al. Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[23] S. Abrignani,et al. Neonatal invariant Vα24+ NKT lymphocytes are activated memory cells , 2000 .
[24] H. Macdonald,et al. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells , 2000, European journal of immunology.
[25] H. Schuitemaker,et al. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Bendelac,et al. Unaltered phenotype, tissue distribution and function of Vα14+ NKT cells in germ‐free mice , 2000, European journal of immunology.
[27] S. Snapper,et al. Cd1-Reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site , 1999, The Journal of experimental medicine.
[28] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[29] L. Kaer,et al. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. , 1999, Journal of immunology.
[30] J. Zack,et al. Reconstitution of Human Thymic Implants Is Limited by Human Immunodeficiency Virus Breakthrough during Antiretroviral Therapy , 1999, Journal of Virology.
[31] Anthony S. Fauci,et al. Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999, Journal of Virology.
[32] D. Littman,et al. Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.
[33] R. Rabin,et al. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. , 1999, Journal of immunology.
[34] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.
[35] M. Bonneville,et al. Diverse CD1d‐restricted reactivity patterns of human T cells bearing “invariant” AV24BV11 TCR , 1998, European journal of immunology.
[36] M. Kronenberg,et al. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.
[37] V. Barnaba,et al. Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.
[38] M. Kronenberg,et al. CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.
[39] S. Porcelli,et al. CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells , 1998, The Journal of experimental medicine.
[40] S. Zolla-Pazner,et al. Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage , 1998, Journal of Virology.
[41] H. Macdonald,et al. Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice , 1998 .
[42] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[43] C. Prussin,et al. TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. , 1997, Journal of immunology.
[44] Hiroshi Sato,et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.
[45] W. Paul,et al. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. , 1997, Journal of immunology.
[46] A. Trkola,et al. Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.
[47] S. Balk,et al. Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.
[48] S. Balk,et al. Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997 .
[49] M. Bonneville,et al. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. , 1997, Journal of immunology.
[50] C. Mackay,et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Herbelin,et al. Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse , 1996, European journal of immunology.
[52] Steven M. Wolinsky,et al. The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.
[53] J J Goedert,et al. Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.
[54] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[55] S. Balk,et al. Human T cells expressing an invariant Va24-JotQ TCRα are CD4- and heterogeneous with respect to TCRβ expression , 1996 .
[56] T. Koike,et al. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. , 1996, Journal of immunology.
[57] S. Kaufmann,et al. Interleukin‐4‐producing CD4+ NK1.1+ TCRα/βintermediate liver lymphocytes are down‐regulated by Listeria monocytogenes , 1995 .
[58] T. Sumida,et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis , 1995, The Journal of experimental medicine.
[59] I. Keet,et al. Lower prevalence and incidence of HIV‐1 syncytium‐inducing phenotype among injecting drug users compared with homosexual men , 1995, AIDS.
[60] C. Sabin,et al. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. , 1995 .
[61] Kees,et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. , 1994, The Journal of clinical investigation.
[62] L. Lanier,et al. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. , 1994, Journal of immunology.
[63] A. Lanzavecchia,et al. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.
[64] M. Wainberg,et al. Cell surface down‐modulation of CD4 after infection by HIV‐1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[66] R. Schwartz,et al. A subset of CD4+ thymocytes selected by MHC class I molecules. , 1994, Science.
[67] S. Balk,et al. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.
[68] M. Martin,et al. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 , 1992, Journal of virology.
[69] L. Kaer,et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice , 2001, Nature Medicine.
[70] D. Mosier. Virus and target cell evolution in human immunodeficiency virus type 1 infection , 2000, Immunologic research.
[71] G. Giaccone,et al. Human natural killer T cells acquire a memory-activated phenotype before birth. , 2000, Blood.
[72] 河野 鉄. CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .
[73] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.